Liu Tao (Chengdu)
Transaction: 12/28/2023
SELL
Change
0
Price
Not reported
Filing
01/26/2024
Type
SELL
China Pharma Holdings, Inc.
CPHI • Drug Manufacturers - Specialty & Generic
$0.83
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$33.71M
Growth
23.1%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive free cash flow · 0Manageable debt level · 0.17Weak liquidity · 0.32Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:12 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.83
Change0.00%
Shares Out40.52M
Market Cap$33.71M
Enterprise Value$-156.48B
52W Range0.38 - 19.19
Beta1.07
P/E-0.00
P/S0.00
P/B0.00
P/FCF-0.00
EV/Sales-0.17
Price$0.83
Change0.00%
Shares Out40.52M
Market Cap$33.71M
Enterprise Value$-156.48B
52W Range0.38 - 19.19
Beta1.07
P/E-0.00
P/S0.00
P/B0.00
P/FCF-0.00
EV/Sales-0.17
EV/EBITDA0.11
EV/FCF1.78
Dividend Yield0.00%
Gross Margin-3.18%
Oper. Margin-74.53%
Profit Margin-76.91%
Debt/Eq0.17
Current Ratio0.32
Quick Ratio0.10
Revenue 5Y23.09%
Volume737.80K
Avg Volume4.44M
EPS Surprise-0.40
Investment DNA
How strong this company looks for long-term investors
32
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
69/100
Why this score▼
Positive free cash flow · 0Manageable debt level · 0.17Weak liquidity · 0.32Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Financial Health
Score8 / 20
Debt / Equity: 0.17
Current Ratio: 0.32
Quick Ratio: 0.10
Status: Moderate
Warnings
- Weak Liquidity
- Weak quick ratio
Insider Transactions
Recent executive and insider activity
⚠ 2 high-volume insider sells detected
Li Zhilin
Transaction: 09/29/2023
BUY
Change
+13,757,063
Price
$0.14
Filing
10/19/2023
Type
BUY
Deng Ke
Transaction: 12/30/2022
SELL
Change
0
Price
Not reported
Filing
03/09/2023
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Liu Tao (Chengdu) | SELL | 0 | Not reported | 12/28/2023 | 01/26/2024 |
| Li Zhilin | BUY | +13,757,063 | $0.14 | 09/29/2023 | 10/19/2023 |
| Deng Ke | SELL | 0 | Not reported | 12/30/2022 | 03/09/2023 |
| Li Zhilin | BUY | +1,760,000 | $0.67 | 09/09/2021 | 09/13/2021 |
| Li Zhilin | BUY | +2,000,000 | Not reported | 12/23/2020 | 01/08/2021 |
| WAUNG FRANK | BUY | +100,000 | Not reported | 04/28/2012 | 05/01/2012 |
| WAUNG FRANK | SELL | -25,000 | $2.54 | 05/25/2011 | 05/01/2012 |
| WAUNG FRANK | SELL | -150,000 | $3.47 | 04/28/2010 | 05/01/2012 |
| WAUNG FRANK | SELL | -10,000 | $2.75 | 10/13/2009 | 05/01/2012 |
| WAUNG FRANK | BUY | +25,000 | $2.54 | 05/25/2011 | 05/27/2011 |
| WAUNG FRANK | BUY | +25,000 | Not reported | 05/25/2011 | 05/27/2011 |
| Li Zhilin | BUY | +25,000 | $2.54 | 05/25/2011 | 05/27/2011 |
| Li Zhilin | BUY | +50,000 | Not reported | 05/25/2011 | 05/27/2011 |
| WAUNG FRANK | BUY | +6,863 | Not reported | 12/13/2010 | 03/02/2011 |
| WAUNG FRANK | BUY | +4,052 | $3.06 | 11/15/2010 | 11/19/2010 |
| WAUNG FRANK | SELL | -40,000 | $2.75 | 11/15/2010 | 11/19/2010 |
| WAUNG FRANK | BUY | +200,000 | $3.47 | 04/28/2010 | 11/19/2010 |
| Tsui Heung Mei | SELL | -1,500,000 | $3.00 | 02/09/2010 | 02/10/2010 |
| DONG BAOWEN | SELL | 0 | Not reported | 02/01/2008 | 10/19/2009 |
| BENNETT G MICHAEL | OTHER | 0 | Not reported | 02/01/2008 | 10/16/2009 |